ES374182A1 - Un procedimiento de preparar una vacuna. - Google Patents

Un procedimiento de preparar una vacuna.

Info

Publication number
ES374182A1
ES374182A1 ES374182A ES374182A ES374182A1 ES 374182 A1 ES374182 A1 ES 374182A1 ES 374182 A ES374182 A ES 374182A ES 374182 A ES374182 A ES 374182A ES 374182 A1 ES374182 A1 ES 374182A1
Authority
ES
Spain
Prior art keywords
vaccine
translation
machine
legally binding
google translate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES374182A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Merieux SA
Original Assignee
Institut Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Merieux SA filed Critical Institut Merieux SA
Publication of ES374182A1 publication Critical patent/ES374182A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/098—Brucella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES374182A 1968-12-04 1969-12-03 Un procedimiento de preparar una vacuna. Expired ES374182A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU57465 1968-12-04

Publications (1)

Publication Number Publication Date
ES374182A1 true ES374182A1 (es) 1972-04-01

Family

ID=19725813

Family Applications (1)

Application Number Title Priority Date Filing Date
ES374182A Expired ES374182A1 (es) 1968-12-04 1969-12-03 Un procedimiento de preparar una vacuna.

Country Status (8)

Country Link
BE (1) BE742586A (de)
BR (1) BR6914736D0 (de)
DE (1) DE1960713C3 (de)
ES (1) ES374182A1 (de)
FR (1) FR2025241A1 (de)
IT (1) IT1043791B (de)
LU (1) LU57465A1 (de)
NL (1) NL6918177A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2516385A1 (fr) * 1981-11-19 1983-05-20 Merieux Inst Vaccin anti-aphteux et anti-colibacillaire et son procede de preparation
NL8301996A (nl) * 1983-06-06 1985-01-02 Duphar Int Res Werkwijze ter bereiding van geadjuveerde levende vaccins en aldus verkregen geadjuveerde levende vaccins.
IL74289A (en) * 1985-02-10 1989-02-28 Israel State Vaccine system comprising a live-non-virulent vaccine and an adjuvant
CN101979503B (zh) * 2010-10-13 2012-05-23 中国兽医药品监察所 表达Asia I型口蹄疫病毒VP1基因的重组布鲁氏菌及其疫苗的生产方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1229677B (de) * 1963-10-25 1966-12-01 Nat Res Dev Verfahren zur Herstellung injizierbarer, Antigene enthaltender Emulsionen

Also Published As

Publication number Publication date
IT1043791B (it) 1980-02-29
DE1960713C3 (de) 1981-12-17
DE1960713A1 (de) 1970-06-18
BR6914736D0 (pt) 1973-02-08
NL6918177A (de) 1970-06-08
LU57465A1 (de) 1970-06-04
BE742586A (de) 1970-06-03
FR2025241A1 (en) 1970-09-04
FR2025241B1 (de) 1974-02-01

Similar Documents

Publication Publication Date Title
SE7505411L (sv) Antigraviditetsvaccin
ES324014A1 (es) Procedimiento de preparacion de composiciones saboreadoras.
NL7506587A (nl) Werkwijze ter bereiding van nieuwe decahydroisochi- nolinederivaten, alsmede werkwijze ter bereiding van farmaceutische preparaten.
ES418690A1 (es) Procedimiento para la preparacion de di-metionil-di-metio- nina.
ES421045A1 (es) Procedimiento para obtencion de proteinas nutritivas de ma-terias queratinosas.
DK137887B (da) Fremgangsmåde til fremstilling af en suspension af et immunstimulerende middel i en injicerbar bærer.
NL174948C (nl) Werkwijze ter bereiding van in de hitte hardbare mengsels, alsmede gevormd voortbrengsel, dat geheel of ten dele daaruit is vervaardigd.
ES419996A1 (es) Un procedimiento para atenuar un virus de diarrea de terne-ros.
ZA734632B (en) Cancer associated polypeptide antigen,process for its preparation,process for preparing antibodies,process of cancer diagnosis and composition useful as an immunizing agent
ES400162A1 (es) Procedimiento para la preparacion de un agente para la in- duccion de una inmunidad precoz, largamente duradera y acre-centada.
ES322985A1 (es) Procedimiento para la preparacion del compuesto lidimicina.
ES308535A1 (es) Procedimiento de obtencion de un haluro de 2:2'-bipiridilo.
ES330862A1 (es) Un procedimiento para la preparacion de alfa, omega-alcohilendiaminas.
NL7508153A (nl) Werkwijze ter bereiding van nieuwe thieno-pyridine- derivaten en werkwijze ter bereiding van farma- ceutische preparaten.
ES381020A1 (es) Procedimiento para la preparacion de un material de colage-no reforzado con fibras.
ES371843A1 (es) Procedimiento para la preparacion de una vacuna.
ES290606A1 (es) Un metodo para la producciën de una vacuna concentrada contra la glosopeda
ES285353A1 (es) Procedimiento de preparación de acetil triftofanato de cafeína
ES330274A1 (es) Procedimiento para preparar una vacuna contra las paperas.
ES294357A1 (es) Procedimiento para la obtención de nuevos nonapepturos
ES318253A1 (es) Procedimiento para la obtenciën de colorantes azoicos
ES297297A1 (es) Un procedimiento para la producciën de una vacuna de virus de sarampiën
ES422331A1 (es) Un procedimiento para preparar un coprecipitado de un agen-te anti-inflamatorio y un lignosulfato soluble en metanol.
ES329634A1 (es) Procedimiento para preparar acidos indolil alifaticos inferiores.
ES293913A1 (es) Procedimiento para preparar pentaformilgitoxina